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Background
In previous studies we showed that in addition to the cyc-
lic nucleotides (cNMPs) cAMP and cGMP, mammalian
cells also contain cCMP and cUMP [for review see [1],
[2]]. cCMP and cUMP are generated by the bacterial exo-
toxins CyaA from Bordetella pertussis and edema factor
(EF) from Bacillus anthracis as well as nitric oxide (NO)-
stimulated soluble guanylyl cyclase (sGC). cCMP and
cUMP activate cAMP-dependent protein kinase (PKA),
cGMP-dependent protein kinase (PKG) and cyclic nucleo-
tide-regulated ion channels (HCN channels). cUMP, but
not cCMP, is degraded by several known phosphodies-
terases (PDEs). cCMP and cUMP are also exported from
cells via multidrug resistance proteins (MRPs 4 and 5).
These findings suggest that cCMP and cUMP constitute
second messenger molecules with distinct signalling
properties.
Pseudomonas aeruginosa is an important pathogenic
bacterium, specifically in patients with cystic fibrosis.
P. aeruginosa injects effector proteins into host cells via
the type III secretion system and, thereby, manipulates
their functions. One of the effector proteins of P. aerugi-
nosa is ExoY. ExoY possesses structural similarity with
CyaA and EF in the catalytic domain and was assumed to
constitute an adenylyl cyclase (AC) [3]. However, the
cAMP-forming capacity of ExoY is rather low. More
recently, it has been shown that ExoY is capable of produ-
cing large quantities of cGMP [4]. On this background, we
examined the question whether ExoY also exhibits cytidy-
lyl- and uridylyl cyclase activity.
Methods
We transfected mammalian cells with a plasmid encoding
ExoY or a catalytically inactive ExoY mutant (ExoY-M).
We also infected cells with P. aeruginosa encoding ExoY
or ExoY-M. In addition, we infected mice intratracheally
with P. aeruginosa. We determined cNMP concentrations
with highly sensitive and specific HPLC-MS/MS and
HPLC-MS/TOF methods. We assessed cell morphology,
apoptosis and label-free dynamic mass distribution, consti-
tuting a holistic and unbiased assay for cell activation.
Results
In all systems studied, we observed striking increases in
cUMP concentrations by ExoY but not by ExoY-M. The
cUMP increase was particularly large in lung tissue follow-
ing infection. One of the reasons for the huge cUMP
increase is the fact that in mouse lung, the activity of
cUMP-degrading PDE is only low. Increases in cCMP and
cGMP were less pronounced. ExoY induced morphologi-
cal changes and cell death. Biological effects of ExoY were
mimicked by the cell membrane-permeable cUMP analog,
cUMP-acetoxymethylester. The biological effects of cUMP
can only be partially explained by activation of PKA and
PKG, indicating that additional and as yet unknown target
proteins are involved in cUMP signal transduction. This
was particularly evident in the dynamic mass distribution
experiments.
Conclusion
In contrast to previous assumptions, ExoY is not an AC
but rather a nucleotidyl cyclase with strong preference for
cGMP- and cUMP production. The large cUMP increases
in the lung following infection with P. aeruginosa suggest
that this cNMP plays a specific role in signal transduction
and in the pathophysiology of lung function. Therefore,
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current research efforts are directed towards the identifica-
tion of specific cUMP-binding proteins using the cNMP
agarose affinity technique [5]. Since there are striking dif-
ferences in degradation of cUMP and cGMP in the lung,
we assume that the two cNMPs exhibit different functions.
Based on the successful uses of PDE5 inhibitors and sGC
activators and stimulators in the therapy of lung diseases,
we envisage substantial clinical potential for cUMP-modu-
lating drugs.
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